Skip to main content
TipRanks
Go Ultimate75% OFF

Kuros Biosciences (0RHR) Income Statement

3 Followers

Kuros Biosciences Income Statement

Last quarter (Q2 2026), Kuros Biosciences's total revenue was CHF72.67M, an increase of 128.21% from the same quarter last year. In Q2, Kuros Biosciences's net income was CHF3.47M. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
CHF 121.30MCHF 75.56MCHF 33.56MCHF 17.99MCHF 13.81M
CHF 104.79MCHF 62.03MCHF 23.94MCHF 10.77MCHF 10.07M
CHF 97.47MCHF 67.03MCHF 38.09MCHF 24.21MCHF 18.83M
Depreciation and AmortizationCHF 2.68MCHF 2.66MCHF 2.75MCHF 2.83MCHF 2.88M
CHF 10.01MCHF -537.00KCHF -6.84MCHF -8.84MCHF -5.29M
CHF 7.33MCHF -5.00MCHF -13.19MCHF -13.45MCHF -8.77M
CHF -3.16MCHF 1.65MCHF -155.00KCHF -2.54MCHF -787.00K
CHF 4.16MCHF -3.35MCHF -9.78MCHF -15.99MCHF -9.55M
CHF 2.12MCHF -3.72MCHF -13.73MCHF -14.60MCHF -7.54M
Per Share Metrics
Basic EPSCHF 0.06CHF -0.10CHF -0.38CHF -0.43CHF -0.23
Diluted EPSCHF 0.05CHF -0.10CHF -0.38CHF -0.43CHF -0.23
Weighted Average Shares Outstanding38.44M37.20M36.58M33.90M32.79M
Weighted Average Shares Outstanding (Diluted)41.39M37.20M36.58M33.90M32.79M

Currency in CHF

Kuros Biosciences Earnings and Revenue History

-80M080M160M-4000 %-2000 %0 %2000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin